- Home
- FXNC vs IPHA Comparison
FXNC vs IPHA Comparison
Compare FXNC & IPHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FXNC
- IPHA
- Stock Information
- Founded
- FXNC 1907
- IPHA 1999
- Country
- FXNC United States
- IPHA France
- Employees
- FXNC N/A
- IPHA N/A
- Industry
- FXNC Major Banks
- IPHA Biotechnology: Pharmaceutical Preparations
- Sector
- FXNC Finance
- IPHA Health Care
- Exchange
- FXNC Nasdaq
- IPHA Nasdaq
- Market Cap
- FXNC 175.2M
- IPHA 160.1M
- IPO Year
- FXNC N/A
- IPHA 2019
- Fundamental
- Price
- FXNC $19.58
- IPHA $2.13
- Analyst Decision
- FXNC Strong Buy
- IPHA Strong Buy
- Analyst Count
- FXNC 1
- IPHA 1
- Target Price
- FXNC $21.00
- IPHA $11.00
- AVG Volume (30 Days)
- FXNC 17.6K
- IPHA 28.4K
- Earning Date
- FXNC 04-30-2025
- IPHA 03-27-2025
- Dividend Yield
- FXNC 3.11%
- IPHA N/A
- EPS Growth
- FXNC N/A
- IPHA N/A
- EPS
- FXNC 0.70
- IPHA N/A
- Revenue
- FXNC $64,227,999.00
- IPHA $20,831,349.00
- Revenue This Year
- FXNC $57.36
- IPHA $209.83
- Revenue Next Year
- FXNC $5.03
- IPHA $83.15
- P/E Ratio
- FXNC $28.39
- IPHA N/A
- Revenue Growth
- FXNC 31.73
- IPHA N/A
- 52 Week Low
- FXNC $14.75
- IPHA $1.29
- 52 Week High
- FXNC $26.97
- IPHA $3.51
- Technical
- Relative Strength Index (RSI)
- FXNC 38.72
- IPHA 49.14
- Support Level
- FXNC $20.18
- IPHA $2.06
- Resistance Level
- FXNC $21.18
- IPHA $2.24
- Average True Range (ATR)
- FXNC 0.41
- IPHA 0.07
- MACD
- FXNC -0.09
- IPHA -0.01
- Stochastic Oscillator
- FXNC 0.00
- IPHA 38.89
About FXNC First National Corporation
First National Corp is a bank holding company of First Bank, which is a commercial bank. Its core offering includes loans, deposits, wealth management, and other products and services. The Company operates through two reportable operating segments: Community Banking and wealth management. The Community Banking segment involves making loans and generating deposits from individuals, businesses, and charitable organizations. Wealth Management Services offers corporate trustee services, trust and estate administration, IRA administration and custody services. Key revenue is generated from Community Banking.
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.